All articles by Bikrant Kumar Singh

  1. June’s top news stories

    AstraZeneca reports positive results from CASPIAN trial of Imfinzi AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the…
    Read More…

    8 Jul
  2. May’s top news stories

    Novartis reports positive results from Phase III trial in asthma Novartis reported that the first clinical trial in its Phase…
    Read More…

    18 Jun
  3. April’s top news stories

    I-Mab and MorphoSys begin Phase III study of blood cancer drug Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech…
    Read More…

    3 May
  4. March’s top news stories

    Aldeyra’s ALLEVIATE trial of reproxalap eyedrops meets endpoints Aldeyra Therapeutics reported positive data from the Phase III ALLEVIATE trial that…
    Read More…

    5 Apr
  5. February’s top news stories

    Eidos Therapeutics starts Phase III trial of AG10 in ATTR-CM Eidos Therapeutics commenced a pivotal Phase III clinical trial of…
    Read More…

    5 Mar
  6. January’s top news stories

    Janssen unblinds Phase III TITAN study for prostate cancer Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III…
    Read More…

    5 Feb
  7. Kolon TissueGene doses first subject in Phase III invossa trial

    Kolon TissueGene has dosed the first patient in a Phase III clinical trial evaluating invossa for the treatment of knee…
    Read More…

    26 Nov
  8. September’s top news stories

    EHP started enrolment in EHP-101 Phase I trial for MS and scleroderma Emerald Health Pharmaceuticals (EHP) started patient enrolment for…
    Read More…

    9 Oct
  9. HPTN reports positive data from HPTN 074 trial for HIV

    HIV Prevention Trials Network (HPTN) has reported positive results from the HPTN 074 trial, which evaluated an integrated intervention of…
    Read More…

    3 Sep
  10. August’s top news stories

    Gradalis commenced Phase lll trial of Vigil in Ewing’s sarcoma Gradalis started a Phase lll clinical trial of Vigil in…
    Read More…

    31 Aug
Close
Close
Close

Go Top